CAR-Tregs

News

Quell Therapeutics changes tack, starting trials of a CAR-Treg in rheumatoid arthritis and systemic sclerosis and parking its transplant therapy.

R&D

Partner Content

Get ready for the much-anticipated return of the 6th Treg-Directed Therapies Summit! This year promises an enhanced experience wi

Views & Analysis

Genome editing is an exciting but still nascent field, and companies in the area face as many obstacles as they do opportunities.